Iterum Therapeutics plc (ITRMF)
SEC filings, insider trading & institutional ownership from EDGAR.
Couldn’t find the data you were looking for?
We haven’t added Iterum Therapeutics plc’s filings yet. We add companies and filings all the time.
Track ITRMF and we’ll email you the moment its filings are in, free and with no account. Or create a free account to request coverage.
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G • latest quarter
| Holder | Filed | Value |
|---|---|---|
| MORGAN STANLEY | May 15, 2026 | $471K |
| UBS Group AG | May 5, 2026 | $96K |
| WELLS FARGO & COMPANY/MN | Jul 8, 2026 | $3K |
ITRMF's filings are public. The insight is one click away.
Scrutar's AI reads every ITRMF filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Never miss a ITRMF filing.
Get an email when ITRMF files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Oct 17, 2026Source: SEC EDGAR.